BackgroundCheck.run
Search For

Mark A Butchko, 52Indianapolis, IN

Mark Butchko Phones & Addresses

Indianapolis, IN   

290 Bentley Dr, Zionsville, IN 46077   

952 Clinton St, Frankfort, IN 46041    765-6594265   

Mishawaka, IN   

1733 Donald St, South Bend, IN 46613    219-2897481   

Wilkes Barre, PA   

Exeter, PA   

Social networks

Mark A Butchko

Linkedin

Work

Company: Eli lilly and company Feb 1, 2010 Position: Senior director, quality assurance - development

Education

Degree: Doctorates, Doctor of Philosophy School / High School: University of Norte Dame 1994 to 2000 Specialities: Philosophy, Organic Chemistry

Skills

Pharmaceutical Industry • Gmp • Quality Assurance • Organic Chemistry • Fda • Validation • Gxp • Change Control • Capa • Sop • Technical Services • Product Development • Drug Development • 21 Cfr Part 11 • Qaqc

Industries

Pharmaceuticals

Mentions for Mark A Butchko

Mark Butchko resumes & CV records

Resumes

Mark Butchko Photo 11

Senior Director, Quality Assurance - Development

Location:
Zionsville, IN
Industry:
Pharmaceuticals
Work:
Eli Lilly and Company
Senior Director, Quality Assurance - Development
Eli Lilly and Company Jun 2008 - Feb 2010
Director, Quality Assurance - Development
Eli Lilly and Company Sep 2005 - Jun 2008
Manager, Chemical Technical Services
Education:
University of Norte Dame 1994 - 2000
Doctorates, Doctor of Philosophy, Philosophy, Organic Chemistry
King's College 1990 - 1994
Bachelors, Bachelor of Science, Chemistry
Skills:
Pharmaceutical Industry, Gmp, Quality Assurance, Organic Chemistry, Fda, Validation, Gxp, Change Control, Capa, Sop, Technical Services, Product Development, Drug Development, 21 Cfr Part 11, Qaqc

Publications & IP owners

Us Patents

Improved Process For The Asymmetric Synthesis Of Duloxetine

US Patent:
2007016, Jul 19, 2007
Filed:
Jan 19, 2006
Appl. No.:
11/275613
Inventors:
Mark Butchko - Frankfort IN, US
Alain Merschaert - Mont Saint Guibert, BE
Kenneth Moder - West Lafayette IN, US
International Classification:
C07D 333/12
US Classification:
549075000
Abstract:
This invention provides an improved asymmetric process for the synthesis of duloxetine involving arylation of Compounds of Formula I.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.